Genetic Modification of the Lung Directed Toward Treatment of Human Disease

In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · see citing works

Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States

Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673 · see citing works

<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587 · see citing works

RNA interference is mediated by 21- and 22-nucleotide RNAsPreprint

Elbashir, S. M., Lendeckel, W., & Tuschl, T. (2001) · Genes & Development · doi:10.1101/gad.862301 · Cited by 3,310 · see citing works

Epidermal growth factor receptor mutations in lung cancer

Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170 · see citing works

Non-viral vectors for gene-based therapy

Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123 · see citing works

Lung Cancer Statistics

Torre, L. A., Siegel, R. L., & Jemal, A. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-24223-1_1 · Cited by 1,913 · see citing works

Synthetic DNA delivery systems

Luo, D., & Saltzman, W. M. (2000) · Nature Biotechnology · doi:10.1038/71889 · Cited by 1,625 · see citing works

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, É., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,574 · see citing works

Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · see citing works

Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

Lane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,493 · see citing works

Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection

Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490 · see citing works

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis

Welsh, M. J., & Smith, A. E. (1993) · Cell · doi:10.1016/0092-8674(93)90353-r · Cited by 1,485 · see citing works

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

Kay, M., Glorioso, J., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,444 · see citing works

Cystic Fibrosis

Rowe, S. M., Miller, S., & Sorscher, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043184 · Cited by 1,398 · see citing works

<i>Pseudomonas aeruginosa</i> : new insights into pathogenesis and host defenses

Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295 · see citing works

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179 · see citing works

The Pathology of Influenza Virus Infections

Taubenberger, J. K., & Morens, D. M. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154316 · Cited by 1,111 · see citing works

Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

Roy, K., Mao, H., Huang, S. K., & Leong, K. W. (1999) · Nature Medicine · doi:10.1038/7385 · Cited by 1,106 · see citing works

The diagnosis of cystic fibrosis: A consensus statement

Rosenstein, B. J., & Cutting, G. R. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70344-0 · Cited by 1,095 · see citing works

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

Yang, Y., Li, Q., Ertl, H. C. J., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,033 · see citing works

Lung cancer: Biology and treatment options

Lemjabbar‐Alaoui, H., Hassan, O. U., Yang, Y., & Buchanan, P. C. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.08.002 · Cited by 1,024 · see citing works

Food allergy

Sicherer, S. H., & Sampson, H. A. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.028 · Cited by 976 · see citing works

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium

Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L. D., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90213-v · Cited by 930 · see citing works

Adeno-associated Virus Serotypes: Vector Toolkit for Human Gene Therapy

Wu, Z., Asokan, A., & Samulski, R. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.009 · Cited by 921 · see citing works

An Animal Model for Cystic Fibrosis Made by Gene Targeting

Snouwaert, J. N., Brigman, K. K., Latour, A. M., Malouf, N. N., Boucher, R. C., Smithies, O., & Koller, B. H. (1992) · Science · doi:10.1126/science.257.5073.1083 · Cited by 919 · see citing works

Site-specific integration by adeno-associated virus.

Kotin, R. M., Siniscalco, M., Samulski, R. J., Zhu, X. D., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., & Berns, K. I. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2211 · Cited by 906 · see citing works

Viral and nonviral delivery systems for gene delivery

Nouri, N., Talebi, M., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 861 · see citing works

Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis

Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. J. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 824 · see citing works

Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung

Pezzulo, A. A., Tang, X. X., Hoegger, M. J., Alaiwa, M. H. A., Ramachandran, S. S., Moninger, T. O., Karp, P. H., Wohlford-Lenane, C., Haagsman, H. P., van Eijk, M., et al. (2012) · Nature · doi:10.1038/nature11130 · Cited by 807 · see citing works

Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression

Samulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742 · see citing works

Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo

Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Pääkkö, P. K., Gilardi‐Hebenstreit, P., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1991) · Science · doi:10.1126/science.2017680 · Cited by 736 · see citing works

Inhibition of respiratory viruses by nasally administered siRNA

Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2004) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725 · see citing works

Genome-editing Technologies for Gene and Cell Therapy

Maeder, M. L., & Gersbach, C. A. (2016) · Molecular Therapy · doi:10.1038/mt.2016.10 · Cited by 722 · see citing works

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

Caplen, N. J., Alton, E. W. F. W., Mddleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S. R., Jeffery, P. K., Hodson, M. E., Coutelle, C. C., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-39 · Cited by 710 · see citing works

Nonviral Gene Delivery: Principle, Limitations, and Recent Progress

Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706 · see citing works

Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.

Roth, J. A., Nguyen, D. M., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R. U., Lee, J. J., Nesbitt, J. C., et al. (1996) · Nature Medicine · doi:10.1038/nm0996-985 · Cited by 702 · see citing works

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

Cohen, C. J., Shieh, J. T. C., Pickles, R. J., Okegawa, T., Hsieh, J., & Bergelson, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261452898 · Cited by 702 · see citing works

Global burden of asthma among children

Asher, I., & Pearce, N. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0170 · Cited by 687 · see citing works

Immune responses to adenovirus and adeno-associated virus in humans

Chirmule, N., Propert, K. J., Magosin, S. A., Qian, Y., Qian, R., & Wilson, J. M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300994 · Cited by 684 · see citing works

Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.

Zabner, J., Couture, L., Gregory, R., Graham, S., Smith, A. E., & Welsh, M. (1993) · Cell · doi:10.1016/0092-8674(93)80063-k · Cited by 657 · see citing works

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., & Kochanek, S. (1998) · Nature Genetics · doi:10.1038/ng0298-180 · Cited by 648 · see citing works

Replacement Therapy for Alpha1-Antitrypsin Deficiency Associated with Emphysema

Wewers, M. D., Casolaro, M. A., Sellers, S. E., Swayze, S. C., McPhaul, K. M., Wittes, J. T., & Crystal, R. G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704233161704 · Cited by 631 · see citing works

Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.

Sánchez‐Céspedes, M., Parrella, P., Esteller, M., Nomoto, S., Trink, B., Engles, J. M., Westra, W. H., Herman, J. G., & Sidransky, D. (2002) · PubMed · Cited by 626 · see citing works

Frequency and Distinctive Spectrum of <i>KRAS</i> Mutations in Never Smokers with Lung Adenocarcinoma

Riely, G. J., Kris, M. G., Rosenbaum, D., Marks, J., Li, A., Chitale, D. A., Nafa, K., Riedel, E. R., Hsu, M., Pao, W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0646 · Cited by 578 · see citing works

Adenovirus vectors for gene therapy, vaccination and cancer gene therapy

Wold, W., & Toth, K. (2014) · Current Gene Therapy · doi:10.2174/1566523213666131125095046 · Cited by 555 · see citing works

An essential receptor for adeno-associated virus infection

Pillay, S., Meyer, N. L., Puschnik, A. S., Davulcu, O., Diep, J., Ishikawa, Y., Jae, L. T., Wosen, J. E., Nagamine, C. M., Chapman, M. S., et al. (2016) · Nature · doi:10.1038/nature16465 · Cited by 532 · see citing works

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

Chapman, K. R., BURDON, J. G. W., Piitulainen, E., Sandhaus, R. A., Seersholm, N. J., Stocks, J. M., Stoel, B. C., Huang, L., Yao, Z., Edelman, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60860-1 · Cited by 516 · see citing works

Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial

Sessa, M., Lorioli, L., Fumagalli, F., Acquati, S., Redaelli, D., Baldoli, C., Canale, S., Lopez, I. D., Morena, F., Calabria, A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30374-9 · Cited by 502 · see citing works

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

Crystal, R. G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114578 · Cited by 498 · see citing works

Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at Birth

Stoltz, D. A., Meyerholz, D. K., Pezzulo, A. A., Ramachandran, S. S., Rogan, M. P., Davis, G. J., Hanfland, R. A., Wohlford-Lenane, C., Dohrn, C. L., Bartlett, J. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000928 · Cited by 496 · see citing works

Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer

Swisher, S. G., Roth, J. A., Nemunaitis, J. J., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Connors, D. G., El‐Naggar, A. K., Fossella, F. V., Glisson, B. S., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.763 · Cited by 495 · see citing works

Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury

Otterbein, L. E., Kolls, J. K., Mantell, L. L., Cook, J. L., Alam, J., & Choi, A. M. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5342 · Cited by 492 · see citing works

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

Flotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B., & Carter, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10613 · Cited by 490 · see citing works

Adenovirus–mediated in vivo gene transfer and expression in normal rat liver

Jaffe, H. A., Danel, C. J., Longenecker, G., Metzger, M. B., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-372 · Cited by 449 · see citing works

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis

Yang, Y., Nunes, F. A., Berencsi, K., Gönczöl, É., Engelhardt, J. F., & Wilson, J. M. (1994) · Nature Genetics · doi:10.1038/ng0794-362 · Cited by 449 · see citing works

Viral Vectors for Gene Therapy: Translational and Clinical Outlook

Kotterman, M. A., Chalberg, T. W., & Schaffer, D. V. (2015) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-104938 · Cited by 444 · see citing works

CRISPR gene-editing tested in a person for the first time

Cyranoski, D. (2016) · Nature · doi:10.1038/nature.2016.20988 · Cited by 442 · see citing works

Liposomes for use in gene delivery

Balazs, D. A., & Godbey, W. (2011) · Journal of Drug Delivery · doi:10.1155/2011/326497 · Cited by 441 · see citing works

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

DeVincenzo, J. P., Lambkin‐Williams, R., Wilkinson, T. M. A., Cehelsky, J. E., Nochur, S., Walsh, E. E., Meyers, R. E., Gollob, J., & Vaishnaw, A. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912186107 · Cited by 440 · see citing works

Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy

Hyde, S. C., Gill, D. R., Higgins, C. F., Trezise, A. E. O., MacVinish, L. J., Cuthbert, A. W., Ratcliff, R. A., Evans, M. J., & Colledge, W. H. (1993) · Nature · doi:10.1038/362250a0 · Cited by 435 · see citing works

Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial

Alton, E. W. F. W., Stern, M., Farley, R., Jaffé, A., Chadwick, S., Phillips, J., Davies, J. C., Smith, S. N., Browning, J. A., Davies, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06532-5 · Cited by 434 · see citing works

Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

Gadek, J. E., Fells, G. A., Zimmerman, R. L., Rennard, S. I., & Crystal, R. G. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110344 · Cited by 429 · see citing works

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

Alton, E. W. F. W., Armstrong, D. K., Ashby, D., Bayfield, K. J., Bilton, D., Bloomfield, E. V., Boyd, A. C., Brand, J., Buchan, R., Calcedo, R., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00245-3 · Cited by 428 · see citing works

Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator.

Poulsen, J. H., Fischer, H., Illek, B., & Machen, T. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5340 · Cited by 420 · see citing works

Alpha 1 -Antitrypsin Deficiency

Silverman, E. K., & Sandhaus, R. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0900449 · Cited by 416 · see citing works

A Review of α1-Antitrypsin Deficiency

Stoller, J. K., & Aboussouan, L. S. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1428ci · Cited by 414 · see citing works

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

Morral, N., O’Neal, W. K., Rice, K., Leland, M. M., Kaplan, J. M., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Córdova, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12816 · Cited by 409 · see citing works

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

Nakao, A., Fujii, M., Matsumura, R., Kumano, K., Saitō, Y., Miyazono, K., & Iwamoto, I. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6094 · Cited by 405 · see citing works

Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

Alton, E. W. F. W., Middleton, P. G., Caplen, N. J., Smith, S. N., Steel, D. M., Munkonge, F. M., Jeffery, P. K., Geddes, D. M., Hart, S. L., Williamson, R., et al. (1993) · Nature Genetics · doi:10.1038/ng1093-135 · Cited by 402 · see citing works

Airway Epithelial Cells: Current Concepts and Challenges

Crystal, R. G., Randell, S. H., Engelhardt, J. F., Voynow, J. A., & Sunday, M. E. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200805-041hr · Cited by 401 · see citing works

Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis

Moss, R. B., Rodman, D. M., Spencer, L. T., Aitken, M. L., Zeitlin, P. L., Waltz, D. A., Milla, C. E., Brody, A. S., Clancy, J. P., Ramsey, B. W., et al. (2004) · CHEST Journal · doi:10.1378/chest.125.2.509 · Cited by 389 · see citing works

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor

Rozmahe, R., Wilschanski, M. A., Matin, A., Plyte, S., Oliver, M. G., Auerbach, W., Moore, A. M., Forstner, J., Durie, P. R., Nadeau, J. H., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-280 · Cited by 385 · see citing works

Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity

Song, W., Kong, H.-L., Carpenter, H., Torii, H., Granstein, R. D., Rafii, S., Moore, M. A. S., & Crystal, R. G. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1247 · Cited by 379 · see citing works

Basolateral Localization of Fiber Receptors Limits Adenovirus Infection from the Apical Surface of Airway Epithelia

Walters, R. W., Grunst, T., Bergelson, J. M., Finberg, R. W., Welsh, M. J., & Zabner, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10219 · Cited by 372 · see citing works

Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis

Sun, X., Sui, H., Fisher, J. T., Yan, Z., Liu, X., Cho, H., Joo, N. S., Zhang, Y., Zhou, W., Yi, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43052 · Cited by 370 · see citing works

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

Nemunaitis, J. J., Dillman, R. O., Schwarzenberger, P. O., Senzer, N. N., Cunningham, C. C., Cutler, J., Tong, A., Kumar, P., Pappen, B. O., Hamilton, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.5335 · Cited by 365 · see citing works

Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans

Grubb, B. R., Pickles, R. J., Ye, H., Yankaskas, J. R., Vick, R. N., Engelhardt, J. F., Wilson, J. M., Johnson, L. G., & Boucher, R. C. (1994) · Nature · doi:10.1038/371802a0 · Cited by 365 · see citing works

Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene

Zhang, W., Yang, H., Kong, X., Mohapatra, S., San-Juan-Vergara, H. G., Hellermann, G., Behera, S., Singam, R., Lockey, R. F., & Mohapatra, S. S. (2004) · Nature Medicine · doi:10.1038/nm1174 · Cited by 364 · see citing works

Pathology of human influenza revisited

Kuiken, T., & Taubenberger, J. K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.025 · Cited by 359 · see citing works

Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype

Gustafsson, J. K., Ermund, A., Ambort, D., Johansson, M., Nilsson, H. E., Thorell, K., Hebert, H., Sjövall, H., & Hansson, G. C. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120562 · Cited by 345 · see citing works

Adenovirus: The First Effective In Vivo Gene Delivery Vector

Crystal, R. G. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.2527 · Cited by 343 · see citing works

Phase 2 Clinical Trial of a Recombinant Adeno-Associated Viral Vector Expressing α ₁ -Antitrypsin: Interim Results

Flotte, T. R., Trapnell, B. C., Humphries, M., Carey, B., Calcedo, R., Rouhani, F., Campbell-Thompson, M., Yachnis, A. T., Sandhaus, R. A., McElvaney, N. G., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.053 · Cited by 335 · see citing works

Lentiviral vectors: basic to translational.

Sakuma, T., Barry, M., & Ikeda, Y. (2012) · Biochemical Journal · doi:10.1042/bj20120146 · Cited by 333 · see citing works

Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.

Carlson, J. A., Rogers, B. B., Sifers, R. N., Finegold, M. J., Clift, S., DeMayo, F. J., Bullock, D. W., & Woo, S. L. C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113999 · Cited by 329 · see citing works

Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy

Brantly, M. L., Chulay, J. D., Wang, L., Mueller, C., Humphries, M., Spencer, L. T., Rouhani, F., Conlon, T. J., Calcedo, R., Betts, M. R., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904514106 · Cited by 327 · see citing works

Functional Repair of Human Donor Lungs by IL-10 Gene Therapy

Cypel, M., Liu, M., Rubacha, M., Yeung, J. C., Hirayama, S., Anraku, M., Sato, M., Medin, J. A., Davidson, B. L., de Perrot, M. E., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000266 · Cited by 326 · see citing works

Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Toxicity Study

Simon, R. H., Engelhardt, J. F., Yang, Y., Zepeda, M. L., Weber-Pendleton, S., S, M. G. B., & Wilson, J. M. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-771 · Cited by 323 · see citing works

Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung Cancer

Nemunaitis, J. J., Swisher, S. G., Timmons, T., Connors, D. E., Mack, M. J., Doerksen, L. F., Weill, D., Wait, J., Lawrence, D. D., Kemp, B. L., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.609 · Cited by 322 · see citing works

Production of CFTR-null and CFTR-ΔF508 heterozygous pigs by adeno-associated virus–mediated gene targeting and somatic cell nuclear transfer

Rogers, C. S., Hao, Y., Rokhlina, T., Samuel, M., Stoltz, D. A., Li, Y., Petroff, E., Vermeer, D. W., Kabel, A. C., Yan, Z., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34773 · Cited by 318 · see citing works

Adeno-Associated Virus Type 6 (AAV6) Vectors Mediate Efficient Transduction of Airway Epithelial Cells in Mouse Lungs Compared to That of AAV2 Vectors

Halbert, C. L., Allen, J. M., & Miller, A. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6615-6624.2001 · Cited by 314 · see citing works

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

Song, S., Morgan, M., Ellis, T., Poirier, A. E., Chesnut, K. A., Wang, J., Brantly, M., Muzyczka, N., Byrne, B. J., Atkinson, M. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14384 · Cited by 305 · see citing works

Ciliated epithelial cell lifespan in the mouse trachea and lung

Rawlins, E. L., & Hogan, B. L. M. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90209.2008 · Cited by 304 · see citing works

In vitro selection, characterization, and application of deoxyribozymes that cleave RNA

Silverman, S. K. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki930 · Cited by 303 · see citing works

Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution

Konstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H., Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1255 · Cited by 298 · see citing works

A mouse model for the delta F508 allele of cystic fibrosis.

Zeiher, B. G., EICHWALD, E. J., Zabner, J., Smith, J. J., Puga, A. P., McCray, P. B., Capecchi, M. R., Welsh, M. J., & Thomas, K. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118253 · Cited by 298 · see citing works

Gene therapy progress and prospects: adenoviral vectors

George, J. A. S. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302071 · Cited by 297 · see citing works

Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics

Mazur, N. I., Martinón‐Torres, F., Baraldi, E., Fauroux, B., Greenough, A., Heikkinen, T., Manzoni, P., Mejías, A., Nair, H., Papadopoulos, N. G., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00255-6 · Cited by 297 · see citing works

Vaccination With Irradiated Autologous Tumor Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor Augments Antitumor Immunity in Some Patients With Metastatic Non–Small-Cell Lung Carcinoma

Salgia, R., Lynch, T. J., Skarin, A. T., Lucca, J. V., Lynch, C., Jung, K., Hodi, F. S., Jaklitsch, M. T., Mentzer, S. J., Swanson, S., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.091 · Cited by 296 · see citing works

Cystic fibrosis in the mouse by targeted insertional mutagenesis

Dorin, J. R., Dickinson, P., Alton, E. W. F. W., Smith, S. N., Geddes, D. M., Stevenson, B. J., Kimber, W. L., Fleming, S., Clarke, A. R., Hooper, M., et al. (1992) · Nature · doi:10.1038/359211a0 · Cited by 294 · see citing works

Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium

Coakley, R. D., Grubb, B. R., Paradiso, A. M., Gatzy, J. T., Johnson, L. G., Kreda, S. M., O’Neal, W. K., & Boucher, R. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634339100 · Cited by 287 · see citing works

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

Giaccone, G., Bazhenova, L. A., Nemunaitis, J., Tan, M., Juhász, E., Ramlau, R., van den Heuvel, M. M., Lal, R., Kloecker, G. H., Eaton, K. D., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.035 · Cited by 279 · see citing works

Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.

Gadek, J. E., Klein, H., Holland, P. V., & Crystal, R. G. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110360 · Cited by 277 · see citing works

Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial

Moss, R. B., Milla, C. E., Colombo, J. L., Accurso, F. J., Zeitlin, P. L., Clancy, J. P., Spencer, L. T., Pilewski, J. M., Waltz, D. A., Dorkin, H. L., et al. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.022 · Cited by 276 · see citing works

Lung Overexpression of the Vascular Endothelial Growth Factor Gene Induces Pulmonary Edema

Kaner, R. J., Ladetto, J. V., Singh, R. N., Fukuda, N., Matthay, M. A., & Crystal, R. G. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.6.3779 · Cited by 272 · see citing works

Aerosol gene delivery in vivo.

Stribling, R., Brunette, E., Liggitt, D., Gaensler, K. M. L., & Debs, R. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11277 · Cited by 270 · see citing works

A Phase II, Double-Blind, Randomized, Placebo-Controlled Clinical Trial of tgAAVCF Using Maxillary Sinus Delivery in Patients with Cystic Fibrosis with Antrostomies

Wagner, J. A., Nepomuceno, I. B., Messner, A. H., Moran, M. L., Batson, E. P., Dimiceli, S., Brown, B. W., Desch, J. K., Norbash, A., Conrad, C., et al. (2002) · Human Gene Therapy · doi:10.1089/104303402760128577 · Cited by 265 · see citing works

Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.

Zabner, J., Ramsey, B. W., Meeker, D. P., Aitken, M. L., Balfour, R., Gibson, R. L., Launspach, J. L., Moscicki, R. A., Richards, S. M., & Standaert, T. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118573 · Cited by 264 · see citing works

Anthrax Pathogenesis

Moayeri, M., Leppla, S. H., Vrentas, C. E., Pomerantsev, A. P., & Liu, S. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104523 · Cited by 263 · see citing works

Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa.

van Heeckeren, A. M., Walenga, R. W., Konstan, M. W., Bonfield, T. L., Davis, P. B., & Ferkol, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119828 · Cited by 262 · see citing works

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

Halbert, C. L., Rutledge, E. A., Allen, J. M., Russell, D. W., & Miller, A. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1524-1532.2000 · Cited by 259 · see citing works

Production of a severe cystic fibrosis mutation in mice by gene targeting

Ratcliff, R. A., Evans, M. J., Cuthbert, A. W., MacVinish, L. J., Foster, D. B., Anderson, J. R., & Colledge, W. H. (1993) · Nature Genetics · doi:10.1038/ng0593-35 · Cited by 258 · see citing works

In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors.

Lemarchand, P., Jones, M., Yamada, I., & Crystal, R. G. (1993) · Circulation Research · doi:10.1161/01.res.72.5.1132 · Cited by 256 · see citing works

Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors.

SUGIURA, K., & Cc, S. (1955) · PubMed · Cited by 254 · see citing works

Adeno-associated virus vectors in gene therapy

Kamieniarz-Gdula, K., & Goździcka‐Józefiak, A. (2005) · Biotechnologia · Cited by 253 · see citing works

Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)

DeVincenzo, J. P., Cehelsky, J., Alvarez, R., Elbashir, S. M., Harborth, J., Toudjarska, I., Nechev, L. V., Murugaiah, V., VLIET, A., & Vaishnaw, A. K. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.009 · Cited by 247 · see citing works

Gene Expression Following Direct Injection of DNA into Liver

Hickman, M. A., Malone, R. W., Lehmann‐Bruinsma, K., Sih, T. R., Knoell, D. L., Szoka, F. C., Walzem, R. L., Carlson, D. M., & Powell, J. S. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.12-1477 · Cited by 245 · see citing works

A mouse model for the cystic fibrosis delta F508 mutation.

van Doorninck, J. H., French, P. J., Verbeek, E., Peters, R. H., Morreau, H., Bijman, J., & Scholte, B. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00119.x · Cited by 245 · see citing works

High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1 -Antitrypsin with Negligible Toxicity

Morral, N., Parks, R. J., Zhou, H., Langston, C., Schiedner, G., Quinones, J., Graham, F. L., Kochanek, S., & Beaudet, A. L. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2709 · Cited by 245 · see citing works

Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes.

Kay, M. A., Baley, P. A., Rothenberg, S., Leland, F. E., Fleming, L. R., Ponder, K. P., Liu, T., Finegold, M. J., Darlington, G., & Pokorny, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.89 · Cited by 245 · see citing works

Efficient gene transfer to airway epithelium using recombinant Sendai virus

Yonemitsu, Y., Kitson, C., Ferrari, S., Farley, R., Griesenbach, U., Judd, D., Steel, R., Scheid, P., Zhu, J., Jeffery, P. K., et al. (2000) · Nature Biotechnology · doi:10.1038/79463 · Cited by 244 · see citing works

Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study

Flotte, T. R., Zeitlin, P. L., Reynolds, T. C., Heald, A. E., Pedersen, P. S., Beck, S. E., Conrad, C., Brass‐Ernst, L., Humphries, M. R., Sullivan, K., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403322124792 · Cited by 244 · see citing works

Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus

Harvey, B., Leopold, P. L., Hackett, N. R., Grasso, T. M., Williams, P. M., Tucker, A. L., Kaner, R. J., Ferris, B., Gonda, I., Sweeney, T. D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7935 · Cited by 244 · see citing works

Granulocyte-Macrophage Colony-Stimulating Factor Gene-Modified Autologous Tumor Vaccines in Non-Small-Cell Lung Cancer

Nemunaitis, J. J., Sterman, D. H., Jablons, D. M., Smith, J. W., Fox, B. A., Maples, P. B., Hamilton, S., Borellini, F., Lin, A., Moralı, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh028 · Cited by 243 · see citing works

A Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung Disease

Aitken, M. L., Moss, R. B., Waltz, D. A., Dovey, M. E., Tonelli, M. R., McNamara, S., Gibson, R. L., Ramsey, B. W., Carter, B. J., & Reynolds, T. C. (2001) · Human Gene Therapy · doi:10.1089/104303401753153956 · Cited by 238 · see citing works

Design of peripheral airways for efficient gas exchange

Weibel, E. R., Sapoval, B., & Filoche, M. (2005) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2005.03.005 · Cited by 236 · see citing works

Treatment of Allergic Airway Inflammation and Hyperresponsiveness by Antisense-Induced Local Blockade of Gata-3 Expression

Finotto, S., Sanctis, G. T. D., Lehr, H. A., Herz, U., Buerke, M., Schipp, M., Bartsch, B., Atreya, R. N., Schmitt, E., Galle, P. R., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1247 · Cited by 234 · see citing works

Mesenchymal stem cell‐based angiopoietin‐1 gene therapy for acute lung injury induced by lipopolysaccharide in mice

Xu, J., Qu, J., Cao, L., Sai, Y., Chen, C., He, L., & Yu, L. (2008) · The Journal of Pathology · doi:10.1002/path.2302 · Cited by 232 · see citing works

Parvovirus replication

Berns, K. I. (1990) · Microbiological Reviews · doi:10.1128/mr.54.3.316-329.1990 · Cited by 232 · see citing works

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

Hyde, S. C., Southern, K., Gileadi, U., Fitzjohn, E., Mofford, K., Waddell, B., Gooi, H. C., Goddard, C., Hannavy, K., Smyth, S., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301212 · Cited by 230 · see citing works

Prevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Types 2, 5, and 6 in Cystic Fibrosis and Normal Populations: Implications for Gene Therapy Using AAV Vectors

Halbert, C. L., Miller, A. D., McNamara, S., Emerson, J., Gibson, R. L., Ramsey, B. W., & Aitken, M. L. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.440 · Cited by 227 · see citing works

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

Sauter, B. V., Martinet, O., Zhang, W., Mandeli, J., & Woo, S. L. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090065597 · Cited by 226 · see citing works

The global burden of chronic respiratory disease in adults

Burney, P., Jarvis, D., & Pérez‐Padilla, R. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0446 · Cited by 225 · see citing works

In vivo model of adeno-associated virus vector persistence and rescue

Afione, S. A., Conrad, C. K., Kearns, W. G., Chunduru, S., Adams, R., Reynolds, T. C., Guggino, W. B., Cutting, G. R., Carter, B. J., & Flotte, T. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3235-3241.1996 · Cited by 223 · see citing works

The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy.

Crystal, R., Brantly, M., Hubbard, R., Curiel, D., States, D., & Holmes, M. (1989) · Chest · doi:10.1378/chest.95.1.196 · Cited by 222 · see citing works

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans

Kampen, K. R. V., Shi, Z., Gao, P., Zhang, J., Foster, K. W., Chen, D., Marks, D. H., Elmets, C. A., & Tang, D.-C. C. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.043 · Cited by 220 · see citing works

Recombinant Adeno-associated Virus Transduction and Integration

Schultz, B. R., & Chamberlain, J. S. (2008) · Molecular Therapy · doi:10.1038/mt.2008.103 · Cited by 216 · see citing works

Generation and characterization of a ΔF508 cystic fibrosis mouse model

Colledge, W. H., Abella, B. S., Southern, K. W., Ratcliff, R. A., Jiang, C., Cheng, S. H., MacVinish, L. J., Anderson, J. R., Cuthbert, A. W., & Evans, M. J. (1995) · Nature Genetics · doi:10.1038/ng0895-445 · Cited by 216 · see citing works

Safety and efficacy of repetitive adenovirus–mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats

Zabner, J., Petersen, D. M., Puga, A. P., Graham, S. M., Couture, L. A., KEYES, L. D., Lukason, M. J., George, J. A. S., Gregory, R. J., Smith, A. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0194-75 · Cited by 212 · see citing works

A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo

Wiseman, J., Goddard, C. A., McLelland, D., & Colledge, W. H. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302050 · Cited by 211 · see citing works

Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

Schüler, M., Herrmann, R., Grève, J. D., Stewart, A. K., Gatzemeier, U., Stewart, D. J., Laufman, L. R., Gralla, R. J., Kuball, J. H. E., Buhl, R., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1750 · Cited by 210 · see citing works

A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer

Ramlau, R., Quoix, É., Rolski, J., Pless, M., Léna, H., Lévy, E., Krzakowski, M. J., Hess, D., Tartour, É., Chenard, M., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31817c6b4f · Cited by 209 · see citing works

Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2a

Engelhardt, J. F., Litzky, L. A., & Wilson, J. M. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.10-1217 · Cited by 209 · see citing works

Safety and Biological Efficacy of an Adeno‐Associated Virus Vector–Cystic Fibrosis Transmembrane Regulator (AAV‐CFTR) in the Cystic Fibrosis Maxillary Sinus

Wagner, J. A., Messner, A. H., Moran, M. L., Daifuku, R., Kouyama, K., Desch, J. K., Manley, S. A., Norbash, A., Conrad, C., Friborg, S., et al. (1999) · The Laryngoscope · doi:10.1097/00005537-199902000-00017 · Cited by 209 · see citing works

Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice

Li, X. M., Chopra, R. K., Chou, T. Y., Schofield, B., Wills-Karp, M. A., & Huang, S. K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3216 · Cited by 209 · see citing works

“Sero-Switch” Adenovirus-Mediated In Vivo Gene Transfer: Circumvention of Anti-Adenovirus Humoral Immune Defenses Against Repeat Adenovirus Vector Administration by Changing the Adenovirus Serotype

Mastrangeli, A., Harvey, B., Yao, J., Wolff, G., Kovesdi, I., Crystal, R. G., & Falck-Pedersen, E. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.1-79 · Cited by 204 · see citing works

Cystic Fibrosis Transmembrane Conductance Regulator Inverts Protein Kinase A-mediated Regulation of Epithelial Sodium Channel Single Channel Kinetics

Stutts, M. J., Rossier, B. C., & Boucher, R. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14037 · Cited by 202 · see citing works

Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems

Rezaee, M., Oskuee, R. K., Nassirli, H., & Malaekeh-Nikouei, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.023 · Cited by 200 · see citing works

Animal models of human respiratory syncytial virus disease

Reinout, A., Domachowske, J. B., & Rosenberg, H. F. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00065.2011 · Cited by 200 · see citing works

Impact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized Mesothelioma

Molnar-Kimber, K. L., Sterman, D. H., Chang, M., Kang, E. H., ElBash, M., Lanuti, M., Elshami, A. A., Gelfand, K., Wilson, J. M., Kaiser, L. R., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.14-2121 · Cited by 200 · see citing works

The Δ F508 Mutation Causes CFTR Misprocessing and Cystic Fibrosis–Like Disease in Pigs

Ostedgaard, L. S., Meyerholz, D. K., Chen, J.-H., Pezzulo, A. A., Karp, P. H., Rokhlina, T., Ernst, S. E., Hanfland, R. A., Reznikov, L. R., Ludwig, P. S., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001868 · Cited by 200 · see citing works

Helper-Dependent Adenoviral Vectors for Gene Therapy

Palmer, D. J., & Ng, P. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1 · Cited by 196 · see citing works

Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.

Conrad, C., Allen, S. S., Afione, S. A., Reynolds, T. C., Beck, S. E., Fee-Maki, M., Barraza-Ortiz, X., Adams, R. J., Askin, F. B., Carter, B. J., et al. (1996) · PubMed · Cited by 196 · see citing works

Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Biological Efficacy Study

Engelhardt, J. F., Simon, R. H., Yang, Y., Zepeda, M. L., Weber-Pendleton, S., Doranz, B. J., S, M. G. B., & Wilson, J. M. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-759 · Cited by 195 · see citing works

Circumvention of Anti-Adenovirus Neutralizing Immunity by Administration of an Adenoviral Vector of an Alternate Serotype

Mack, C. A., Song, W., Carpenter, H., Wickham, T., Kovesdi, I., Harvey, B., Magovern, C. J., Isom, O. W., Rosengart, T. K., Falck-Pedersen, E., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-99 · Cited by 192 · see citing works

Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.

Kearns, W. G., Afione, S. A., Fulmer, S. B., Pang, M. C., Erikson, D., Egan, M. E., Landrum, M., Flotte, T. R., & Cutting, G. R. (1996) · PubMed · Cited by 191 · see citing works

Role of epithelial HCO 3 − transport in mucin secretion: lessons from cystic fibrosis

Quinton, P. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00362.2010 · Cited by 190 · see citing works

Baculovirus: an Insect-derived Vector for Diverse Gene Transfer Applications

Airenne, K. J., Hu, Y., Kost, T. A., Smith, R. H., Kotin, R. M., Ono, C., Matsuura, Y., Wang, S., & Ylä‐Herttuala, S. (2013) · Molecular Therapy · doi:10.1038/mt.2012.286 · Cited by 190 · see citing works

Type 1 Interferons and Antiviral CD8 T-Cell Responses

Welsh, R. M., Bahl, K., Marshall, H. D., & Urban, S. L. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002352 · Cited by 189 · see citing works

Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.

Wang, Y.-H., Su, H.-H., Yang, Y., Hu, Y.-X., Zhang, L., Blancafort, P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.250 · Cited by 189 · see citing works

The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration

Cieslewicz, G., Tomkinson, A., Adler, A., Duez, C., Schwarze, J., Takeda, K., Larson, K. A., Lee, J. J., Irvin, C. G., & Gelfand, E. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7010 · Cited by 189 · see citing works

Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.

Yei, S., Mittereder, N., Tang, K., O’Sullivan, C., & Trapnell, B. C. (1994) · PubMed · Cited by 189 · see citing works

Linear DNAs Concatemerize in Vivo and Result in Sustained Transgene Expression in Mouse Liver

Chen, Z.-Y., Yant, S. R., He, C.-Y., Meuse, L. A., Shen, S., & Kay, M. A. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0278 · Cited by 186 · see citing works

Targeted gene delivery of BMPR2 attenuates pulmonary hypertension

Reynolds, A. M., Holmes, M., Danilov, S. M., & Reynolds, P. N. (2011) · European Respiratory Journal · doi:10.1183/09031936.00187310 · Cited by 186 · see citing works

PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers

Jin, G., Kim, M. J., Jeon, H., Choi, J. E., Kim, D. S., Lee, E. B., Ick, S., Yoon, G. S., Kim, C. H., Jung, T. H., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.012 · Cited by 185 · see citing works

Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans

Lu, C., Stewart, D. J., Lee, J. J., Ji, L., Ramesh, R., Jayachandran, G., Nunez, M. I., Wistuba, I. I., Erasmus, J. J., Hicks, M. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034833 · Cited by 184 · see citing works

A Clinical Inflammatory Syndrome Attributable to Aerosolized Lipid–DNA Administration in Cystic Fibrosis

Ruiz, F. E., Clancy, J. P., Perricone, M. A., Bebok, Z. M., Hong, J. S., Cheng, S. H., Meeker, D. P., Young, K. R., Schoumacher, R., Weatherly, M. R., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750148667 · Cited by 184 · see citing works

Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy

Epperly, M. W., Bray, J. A., Stephen, K., Zwacka, R. M., Engelhardt, J. F., Travis, E. L., & Greenberger, J. S. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300580 · Cited by 182 · see citing works

Transduction Efficiencies of Novel AAV Vectors in Mouse Airway Epithelium In Vivo and Human Ciliated Airway Epithelium In Vitro

Limberis, M. P., Vandenberghe, L. H., Zhang, L., Pickles, R. J., & Wilson, J. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.261 · Cited by 180 · see citing works

The α1-antitrypsin gene and its deficiency states

Crystal, R. G. (1989) · Trends in Genetics · doi:10.1016/0168-9525(89)90200-x · Cited by 179 · see citing works

Regional Suppression of Tumor Growth by In Vivo Transfer of a cDNA Encoding a Secreted Form of the Extracellular Domain of the flt-1 Vascular Endothelial Growth Factor Receptor

Kong, H.-L., Hecht, D., Song, W., Kovesdi, I., Hackett, N. R., Yayon, A., & Crystal, R. G. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.6-823 · Cited by 179 · see citing works

Immunity to adeno-associated virus vectors in animals and humans: a continued challenge

Zaiss, A. K., & Muruve, D. A. (2008) · Gene Therapy · doi:10.1038/gt.2008.54 · Cited by 179 · see citing works

Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX® vaccine in advanced-stage non-small-cell lung cancer

Nemunaitis, J. J., Jahan, T. M., Ross, H. J., Sterman, D. H., Richards, D., Fox, B. A., Jablons, D. M., Aimi, J., Lin, A., & Hege, K. M. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700922 · Cited by 179 · see citing works

Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Serotype 2 α 1-Antitrypsin (AAT) Vector in AAT-Deficient Adults

Brantly, M., Spencer, L. T., Humphries, M. R., Conlon, T. J., Spencer, C. T., Poirier, A. E., Garlington, W., Baker, D. J., Song, S., Berns, K. I., et al. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1177 · Cited by 177 · see citing works

Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical Trial

Bellon, G., Michel‐Calemard, L., Thouvenot, D., Jagneaux, V., Poitevin, F., Malcus, C., Accart, N., Layani, M. P., Aymard, M., Bernon, H., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-15 · Cited by 177 · see citing works

Aerosol and Intravenous Transfection of Human α1-Antitrypsin Gene to Lungs of Rabbits

Canonico, A. E., Conary, J. T., Meyrick, B. O., & Brigham, K. L. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.1.8292378 · Cited by 175 · see citing works

Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure

Zhang, G., Song, Y., & Liu, D. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301229 · Cited by 171 · see citing works

Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung afterin vivointratracheal plasmid-mediated gene transfer

Yoshimura, K., Rosenfeld, M. A., Nakamura, H., Scherer, E. M., Pavirani, A., Lecocq, J., & Crystal, R. G. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.12.3233 · Cited by 171 · see citing works

Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In Vivo

Kay, M. A., Li, Q., Liu, T.-J., Leland, F. E., Toman, C. J., Finegold, M. J., & Woo, S. L. C. (1992) · Human Gene Therapy · doi:10.1089/hum.1992.3.6-641 · Cited by 170 · see citing works

Occurrence of leukaemia following gene therapy of X-linked SCID

Kohn, D., Sadelain, M., & Glorioso, J. (2003) · Nature Reviews. Cancer · doi:10.1038/nrc1122 · Cited by 170 · see citing works

Preclinical Murine Models for Lung Cancer: Clinical Trial Applications

Kellar, A., Egan, C., & Morris, D. G. (2015) · BioMed Research International · doi:10.1155/2015/621324 · Cited by 170 · see citing works

Anti-Vascular Endothelial Growth Factor Gene Therapy Attenuates Lung Injury and Fibrosis in Mice

Hamada, N., Kuwano, K., Yamada, M., Hagimoto, N., Hiasa, K., Egashira, K., Nakashima, N., Maeyama, T., Yoshimi, M., & Nakanishi, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1224 · Cited by 170 · see citing works

Human Treg responses allow sustained recombinant adeno-associated virus–mediated transgene expression

Mueller, C., Chulay, J. D., Trapnell, B. C., Humphries, M., Carey, B., Sandhaus, R. A., McElvaney, N. G., Messina, L., Tang, Q., Rouhani, F. N., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70314 · Cited by 169 · see citing works

Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

Rudin, C. M., Salgia, R., Wang, X., Hodgson, L. D., Masters, G. A., Green, M., & Vokes, E. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3461 · Cited by 166 · see citing works

Adeno-Associated Virus as a Vector for Liver-Directed Gene Therapy

Xiao, W., Berta, S. C., Lu, M. M., Moscioni, A. D., Tazelaar, J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10222-10226.1998 · Cited by 166 · see citing works

Phase I Study of G3139, a bcl-2 Antisense Oligonucleotide, Combined With Carboplatin and Etoposide in Patients With Small-Cell Lung Cancer

Rudin, C. M., Kozloff, M. F., Hoffman, P. C., Edelman, M. J., Karnauskas, R., Tomek, R., Szeto, L. L., & Vokes, E. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.148 · Cited by 166 · see citing works

Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?

Rayburn, E. R., & Zhang, R. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.014 · Cited by 165 · see citing works

A Phase I Study of Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients with Advanced Non-Small Cell Lung Cancer

Schüler, M., Rochlitz, C. F., Horowitz, J. A., Schlegel, J., Perruchoud, A. P., Kommoss, F., Bolliger, C. T., Kauczor, H., Dalquen, P., Fritz, M. A., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.14-2075 · Cited by 165 · see citing works

Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy.

Griesenbach, U., & Alton, E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.010 · Cited by 163 · see citing works

Retargeting the Coxsackievirus and Adenovirus Receptor to the Apical Surface of Polarized Epithelial Cells Reveals the Glycocalyx as a Barrier to Adenovirus-Mediated Gene Transfer

Pickles, R. J., Fahrner, J. A., Petrella, J. M., Boucher, R. C., & Bergelson, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.6050-6057.2000 · Cited by 160 · see citing works

Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors

Hill, A. B., Chen, M., Chen, C., Pfeifer, B. A., & Jones, C. H. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.11.004 · Cited by 160 · see citing works

Chinese scientists to pioneer first human CRISPR trial

Cyranoski, D. (2016) · Nature · doi:10.1038/nature.2016.20302 · Cited by 160 · see citing works

Adeno-associated virus serotypes for gene therapeutics

Lisowski, L., Tay, S. S., & Alexander, I. E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.07.006 · Cited by 159 · see citing works

Antisense Therapy against CCR3 and the Common Beta Chain Attenuates Allergen-induced Eosinophilic Responses

Gauvreau, G. M., Boulet, L., Cockcroft, D. W., Baatjes, A. J., Côté, J., Deschesnes, F., Davis, B. E., Strinich, T. X., Howie, K. J., Duong, M. T., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1251oc · Cited by 158 · see citing works

Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect

Wang, G., Slepushkin, V., Zabner, J., Keshavjee, S. H., Johnston, J., Sauter, S. L., Jolly, D. J., Dubensky, T. W., Davidson, B. L., & McCray, P. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8390 · Cited by 157 · see citing works

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

Gurwith, M., Lock, M. D., Taylor, E. M., Ishioka, G. Y., Alexander, J., Mayall, T., Ervin, J. E., Greenberg, R. N., Strout, C. B., Treanor, J. J., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70345-6 · Cited by 157 · see citing works

A Phase I Clinical Trial of Single-Dose Intrapleural IFN-β Gene Transfer for Malignant Pleural Mesothelioma and Metastatic Pleural Effusions: High Rate of Antitumor Immune Responses

Sterman, D. H., Recio, A., Carroll, R. G., Gillespie, C. T., Haas, A. R., Vachani, A., Kapoor, V., Sun, J., Hodinka, R. L., Brown, J. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0403 · Cited by 157 · see citing works

A Phase I Study of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to a Lung Segment of Individuals with Cystic Fibrosis

Zuckerman, J. B., Robinson, C. B., M, K. S., SHELL, R. D., Sferra, T. J., Chirmule, N. B., Magosin, S., PROPERT, K. J., Brown-Parr, E. C., Hughes, J. V., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950016384 · Cited by 155 · see citing works

A pilot trial of G3139, a bcl-2 antisense oligonucleotide,and paclitaxel in patients with chemorefractory small-cell lung cancer

Rudin, C. M., Otterson, G. A., Mauer, A. M., Villalona-Calero, M. A., Tomek, R. M., Prange, B., George, C., Szeto, L. L., & Vokes, E. E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf124 · Cited by 155 · see citing works

Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered

Limberis, M. P., & Wilson, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601433103 · Cited by 154 · see citing works

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview

Issa, S. S., Shaimardanova, A. A., Solovyeva, V. V., & Rizvanov, A. A. (2023) · Cells · doi:10.3390/cells12050785 · Cited by 319 · see citing works

Gene editing and CRISPR in the clinic: current and future perspectives

Hirakawa, M. P., Krishnakumar, R., Timlin, J. A., Carney, J. P., & Butler, K. S. (2020) · Bioscience Reports · doi:10.1042/bsr20200127 · Cited by 197 · see citing works

Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing

Maule, G., Casini, A., Montagna, C., Ramalho, A. S., De Boeck, K., Debyser, Z., Carlon, M. S., Petris, G., & Cereseto, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11454-9 · Cited by 86 · see citing works

Ex-vivo Kidney Machine Perfusion: Therapeutic Potential

Žulpaitė, R., Miknevicius, P., Leber, B., Strupas, K., Stiegler, P., & Schemmer, P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.808719 · Cited by 81 · see citing works

Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion

Yuzefovych, Y., Valdivia, E., Rong, S., Hack, F., Rother, T., Schmitz, J., Bräsen, J. H., Wedekind, D., Moers, C., Wenzel, N., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00265 · Cited by 70 · see citing works

The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach

Wu, D., Song, J., Bartel, S., Krauss‐Etschmann, S., Rots, M. G., & Hylkema, M. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.007 · Cited by 49 · see citing works

Lessons learned from lung and liver in-vivo gene therapy: implications for the future

van Haasteren, J., Hyde, S. C., & Gill, D. R. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1506761 · Cited by 40 · see citing works

Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?

Avcı, E., Sarvari, P., Savai, R., Seeger, W., & Pullamsetti, S. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010546 · Cited by 33 · see citing works

Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases

Bisserier, M., Sun, X., Fazal, S., Turnbull, I. C., Bonnet, S., & Hadri, L. (2022) · Cells · doi:10.3390/cells11060984 · Cited by 34 · see citing works

Gene Therapy in Rare Respiratory Diseases: What Have We Learned So Far?

Bañuls, L., Pellicer, D., Castillo, S., Navarro‐García, M. M., Magallón, M., González, C., & Dası́, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082577 · Cited by 31 · see citing works

One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies

Ensinck, M. M., & Carlon, M. S. (2022) · Cells · doi:10.3390/cells11121868 · Cited by 31 · see citing works

Progress in Respiratory Gene Therapy

McLachlan, G., Alton, E., Boyd, A., Clarke, N. K., Davies, J., Gill, D., Griesenbach, U., Hickmott, J., Hyde, S., Miah, K., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.172 · Cited by 26 · see citing works

Nucleic acid combinations: A new frontier for cancer treatment

Remant Bahadur, K. C., Thapa, B., Valencia‐Serna, J., Aliabadi, H. M., & Uludağ, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.029 · Cited by 30 · see citing works

Assessing Human Airway Epithelial Progenitor Cells for Cystic Fibrosis Cell Therapy

Lee, R. E., Miller, S. M., Mascenik, T., Lewis, C. A., Dang, H., Boggs, Z. H., Tarran, R., & Randell, S. H. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0384oc · Cited by 28 · see citing works

An update on new and emerging therapies for cystic fibrosis

Hudock, K. M., & Clancy, J. P. (2017) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2017.1418324 · Cited by 28 · see citing works

Advances in Alpha-1 Antitrypsin Gene Therapy

Lőrincz, R., & Curiel, D. T. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0159ps · Cited by 28 · see citing works

Induced Pluripotent Stem Cells for Primary Ciliary Dyskinesia Modeling and Personalized Medicine

Mianné, J., Ahmed, E., Bourguignon, C., Fieldès, M., Vachier, I., BOURDIN, A. A., Assou, S., & Vos, J. D. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0213tr · Cited by 28 · see citing works

On the Corner of Models and Cure: Gene Editing in Cystic Fibrosis

Ensinck, M. M., Mottais, A., Detry, C., Leal, T., & Carlon, M. S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.662110 · Cited by 28 · see citing works

Mechanism-Based Personalized Medicine for Cystic Fibrosis by Suppressing Pseudo Exon Inclusion

Shibata, S., Ajiro, M., & Hagiwara, M. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.08.013 · Cited by 23 · see citing works

Immunomodulation of the donor lung with CRISPR-mediated activation of IL-10 expression

Mesaki, K., Juvet, S., Yeung, J. C., Guan, Z., Wilson, G. W., Hu, J., Davidson, A. R., Kleinstiver, B. P., Cypel, M., Liu, M., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.06.001 · Cited by 24 · see citing works

Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease

Stiles, K. M., Sondhi, D., Kaminsky, S. M., De, B. P., Rosenberg, J. B., & Crystal, R. G. (2018) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.5.4.2017.0160 · Cited by 18 · see citing works

The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?

Oliver, K. E., Carlon, M. S., Pedemonte, N., & Lopes‐Pacheco, M. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2230129 · Cited by 18 · see citing works

Gene Therapy for Acute Respiratory Distress Syndrome

Liu, J., & Dean, D. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.786255 · Cited by 16 · see citing works

Roadmap for an early gene therapy for cystic fibrosis airway disease

Carlon, M. S., Vidović, D., & Birket, S. E. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5164 · Cited by 16 · see citing works

Rewriting CFTR to cure cystic fibrosis

Maule, G., Ensinck, M. M., Bulcaen, M., & Carlon, M. S. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.12.018 · Cited by 16 · see citing works

A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting

Lu, Z. H., Dmitriev, I. P., Brough, D. E., Kashentseva, E. A., Li, J., & Curiel, D. T. (2020) · Journal of Virology · doi:10.1128/jvi.00265-20 · Cited by 14 · see citing works

Intra-tracheal delivery of AAV6 vectors results in sustained transduction in murine lungs without genomic integration

Colon-Cortes, Y., Hasan, M. A., & Aslanidi, G. (2020) · Gene · doi:10.1016/j.gene.2020.100037 · Cited by 10 · see citing works

Anticipating New Treatments for Cystic Fibrosis: A Global Survey of Researchers

Cabral, B. P., Terlizzi, V., Laselva, O., Filho, C. G. C., & Mota, F. B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051283 · Cited by 12 · see citing works

mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications

Joshi, R., Sharma, S., Kapoor, D. U., Prajapati, B. G., Huanbutta, K., & Sriamornsak, P. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00774 · Cited by 10 · see citing works

Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy

Dai, L., & Du, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.961848 · Cited by 8 · see citing works

A Critical Reason for Conducting Clinical Trials Is that Results with Humans Are Not Necessarily Predictable from Preclinical Studies

Baum, B. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-78205-8_7 · Cited by 2 · see citing works

DNA complexes as an efficient gene anticancer drug delivery therapy

Madkour, L. H. (2019) · Nucleic Acids as Gene Anticancer Drug Delivery Therapy · doi:10.1016/b978-0-12-819777-6.00020-2

Liquid Ventilation in the Management of Preterm Infants

Kotzur, T. M., Tilden, S. A., & Partridge, E. A. (2021) · Current Stem Cell Reports · doi:10.1007/s40778-021-00192-8

References

(2018) · Wiley-VCH eBooks · doi:10.1002/9783527692903.refs

Modélisation de l'épithélium bronchique par les cellules souches pluripotentes induites humaines dans la Bronchopathie Pulmonaire Chronique Obstructive (BPCO)

Ahmed, E. (2018) · theses.fr (ABES) · doi:10.70675/8018a362z30fez4067za42dz3f220845641c

Thérapie génique par CRISPR/Cas9 pour corriger des épithéliums bronchiques dérivés de cellules souches pluripotentes induites (iPSCs) de patients atteints de dyskinésie ciliaire primitive (DCP) : une preuve de concept

Mianné, J. (2020) · theses.fr (ABES) · doi:10.70675/179210b5z933bz4406zb297z7beef82bc3ae

Prospects for gene therapy in lung disease

Davies, J. C. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00048-0 · Cited by 12 · see citing works

Gene Therapy for Inherited Lung Disorders: An Insight into Pulmonary Defence

Vadolas, J., Williamson, R., & Ioannou, P. A. (2002) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0316 · Cited by 24 · see citing works

Gene Therapy for Lung Disease: Hype or Hope?

Albelda, S. Μ., Wiewrodt, R. G., & Zuckerman, J. B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-8-200004180-00008 · Cited by 71 · see citing works

Gene Therapy for Lung Diseases Development in the Vector Biology and Novel Concepts for Gene Therapy Applications

Suzuki, M., Matsuse, T., & Isigatsubo, Y. (2001) · Current Molecular Medicine · doi:10.2174/1566524013364086 · Cited by 15 · see citing works

Gene Therapy Approaches for Inherited and Acquired Lung Diseases

Curiel, D. T., Pilewski, J. M., & Albelda, S. Μ. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.14.1.8534480 · Cited by 94 · see citing works